Fate of anticancer drugs in the environment
Anticancer drugs: potantial risks in the environment
Article REF: PHA3030 V1
Fate of anticancer drugs in the environment
Anticancer drugs: potantial risks in the environment

Authors : Jordan SEIRA, Claire JOANNIS-CASSAN, Claire ALBASI

Publication date: March 10, 2014 | Lire en français

Logo Techniques de l'Ingenieur You do not have access to this resource.
Request your free trial access! Free trial

Already subscribed?

2. Fate of anticancer drugs in the environment

The behavior of targeted anticancer molecules is studied here from their consumption by the patient to their emission into the environment, which are the boundaries of the system under consideration. Upstream stages (drug manufacture, marketing authorization, etc.) and downstream stages (water reuse, drinking water production, etc.) are not covered. A summary diagram of this study system is shown in figure 3

You do not have access to this resource.
Logo Techniques de l'Ingenieur

Exclusive to subscribers. 97% yet to be discovered!

You do not have access to this resource. Click here to request your free trial access!

Already subscribed?


Ongoing reading
Fate of anticancer drugs in the environment

Article included in this offer

"Environment manager"

( 296 articles )

Complete knowledge base

Updated and enriched with articles validated by our scientific committees

Services

A set of exclusive tools to complement the resources

View offer details